Search Results - "Craviotto, Luisa"

Refine Results
  1. 1

    CD14+CD16+ monocytes are involved in daratumumab‐mediated myeloma cells killing and in anti‐CD47 therapeutic strategy by Storti, Paola, Vescovini, Rosanna, Costa, Federica, Marchica, Valentina, Toscani, Denise, Dalla Palma, Benedetta, Craviotto, Luisa, Malavasi, Fabio, Giuliani, Nicola

    Published in British journal of haematology (01-08-2020)
    “…Summary A deep elucidation of the mechanisms of action of anti‐CD38 monoclonal antibodies (mAbs), such as daratumumab (DARA), is required to identify patients…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A misleading miscellanea: a COVID-19 patient with fever and cytopenia by Bocchi, Pietro, Zerbini, Lara, Gnappi, Elisa, Ziliotti, Maurizio, Pesci, Marco, Craviotto, Luisa, Meschi, Michele

    Published in Italian journal of medicine (04-11-2024)
    “…Complex clinical cases characterized by the coexistence of multiple pathologies and, consequently, multiple signs and symptoms shared by various pathological…”
    Get full text
    Journal Article
  4. 4

    Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma by Romano, Alessandra, Storti, Paola, Marchica, Valentina, Scandura, Grazia, Notarfranchi, Laura, Craviotto, Luisa, Di Raimondo, Francesco, Giuliani, Nicola

    Published in Frontiers in oncology (08-07-2021)
    “…Monoclonal antibodies (mAbs) directed against antigen-specific of multiple myeloma (MM) cells have Fc-dependent immune effector mechanisms, such as…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The Role of Proteasome Inhibitors in Multiple Myeloma Bone Disease and Bone Metastasis: Effects on Osteoblasts and Osteocytes by Toscani, Denise, Craviotto, Luisa, Giuliani, Nicola

    Published in Applied sciences (01-05-2021)
    “…The alterations of bone remodeling are typical of multiple myeloma (MM) patients where the uncoupled and unbalanced bone remodeling caused the onset of…”
    Get full text
    Journal Article
  7. 7

    Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets by Burroughs Garcìa, Jessica, Eufemiese, Rosa Alba, Storti, Paola, Sammarelli, Gabriella, Craviotto, Luisa, Todaro, Giannalisa, Toscani, Denise, Marchica, Valentina, Giuliani, Nicola

    Published in Cells (Basel, Switzerland) (01-06-2021)
    “…Multiple myeloma (MM) is characterized by an accumulation of malignant plasma cells (PCs) in the bone marrow (BM). The amplification of 1q21 is one of the most…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression by Dalla Palma, Benedetta, Marchica, Valentina, Accardi, Fabrizio, Guasco, Daniela, Notarfranchi, Laura, Costa, Federica, Caviola, Martina, De Luca, Federica, Craviotto, Luisa, Pedrazzoni, Mario, Aversa, Franco, Giuliani, Nicola

    Published in Blood (02-12-2016)
    “…The presence of bone disease is the hallmark to differentiate patients with active multiple myeloma (MM) from those with smoldering MM (SMM). The diagnostic…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20